116 related articles for article (PubMed ID: 35705022)
1. Breast Cancer Patients Are at Increased Risk of Developing Uterine Serous Cancer: Implications for Counseling - A SEER Analysis.
Nahshon C; Segev Y; Schmidt M; Shulman K; Lavie O
Oncol Res Treat; 2022; 45(12):728-735. PubMed ID: 35705022
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characteristics and prognosis of uterine serous carcinoma: A SEER program analysis of 1016 cases.
Han Y; Liu C
J Obstet Gynaecol Res; 2021 Jul; 47(7):2460-2472. PubMed ID: 33870589
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database.
Li S; Yang J; Shen Y; Zhao X; Zhang L; Wang B; Li P; Wang Y; Yi M; Yang J
BMC Public Health; 2019 Nov; 19(1):1592. PubMed ID: 31783815
[TBL] [Abstract][Full Text] [Related]
4. BRCA germline mutations in women with uterine serous carcinoma--still a debate.
Lavie O; Ben-Arie A; Segev Y; Faro J; Barak F; Haya N; Auslender R; Gemer O
Int J Gynecol Cancer; 2010 Dec; 20(9):1531-4. PubMed ID: 21119368
[TBL] [Abstract][Full Text] [Related]
5. Association between uterine serous carcinoma and breast cancer.
Gehrig PA; Bae-Jump VL; Boggess JF; Groben PA; Fowler WC; Van Le L
Gynecol Oncol; 2004 Jul; 94(1):208-11. PubMed ID: 15262144
[TBL] [Abstract][Full Text] [Related]
6. Linking uterine serous carcinoma to BRCA1/2-associated cancer syndrome: A meta-analysis and case report.
de Jonge MM; Mooyaart AL; Vreeswijk MP; de Kroon CD; van Wezel T; van Asperen CJ; Smit VT; Dekkers OM; Bosse T
Eur J Cancer; 2017 Feb; 72():215-225. PubMed ID: 28049106
[TBL] [Abstract][Full Text] [Related]
7. Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?
Boruta DM; Gehrig PA; Groben PA; Bae-Jump V; Boggess JF; Fowler WC; Van Le L
Cancer; 2004 Nov; 101(10):2214-21. PubMed ID: 15452833
[TBL] [Abstract][Full Text] [Related]
8. Poor prognosis of uterine serous carcinoma compared with grade 3 endometrioid carcinoma in early stage patients.
Park JY; Nam JH; Kim YT; Kim YM; Kim JH; Kim DY; Sohn I; Lee SW; Sung CO; Kim KR
Virchows Arch; 2013 Mar; 462(3):289-96. PubMed ID: 23417747
[TBL] [Abstract][Full Text] [Related]
9. Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning.
Nolin AC; Tian C; Hamilton CA; Casablanca Y; Bateman NW; Chan JK; Cote ML; Shriver CD; Powell MA; Phippen NT; Conrads TP; Maxwell GL; Darcy KM
Gynecol Oncol; 2022 Jul; 166(1):90-99. PubMed ID: 35624045
[TBL] [Abstract][Full Text] [Related]
10. A 4-gene signature predicts prognosis of uterine serous carcinoma.
Chen H; Li L; Qin P; Xiong H; Chen R; Zhang M; Jiang Q
BMC Cancer; 2021 Feb; 21(1):154. PubMed ID: 33579221
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive lymphadenectomy and survival prediction in uterine serous cancer patients after surgery: A population-based analysis.
Li H; Xie X; Liu Y; Huang X; Lin H; Li J; Lin Z
Eur J Surg Oncol; 2020 Jul; 46(7):1339-1346. PubMed ID: 32402510
[TBL] [Abstract][Full Text] [Related]
12. Correlation of tumor size with other prognostic factors in uterine serous carcinoma: a large multi-institutional study.
Winer I; Mahdi H; Bandyopadhyay S; Semaan A; Van de Vijver KK; Nucci MR; Abdul-Karim F; Hussein Y; Qureshi F; Hayek K; Alosh B; Schulz D; Cote M; Munkarah A; Morris R; Oliva E; Ali-Fehmi R
Gynecol Oncol; 2013 Feb; 128(2):316-21. PubMed ID: 23138135
[TBL] [Abstract][Full Text] [Related]
13. BRCA1/2 germline mutations in Jewish patients with uterine serous carcinoma.
Bruchim I; Amichay K; Kidron D; Attias Z; Biron-Shental T; Drucker L; Friedman E; Werner H; Fishman A
Int J Gynecol Cancer; 2010 Oct; 20(7):1148-53. PubMed ID: 21206239
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
[TBL] [Abstract][Full Text] [Related]
15. HER-2 Amplification in Uterine Serous Carcinoma and Serous Endometrial Intraepithelial Carcinoma.
Banet N; Shahi M; Batista D; Yonescu R; Tanner EJ; Fader AN; Cimino-Mathews A
Am J Surg Pathol; 2021 May; 45(5):708-715. PubMed ID: 33739786
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.
Wong SM; Ajjamada L; Weiss AC; Prakash I; Skamene S; Boileau JF; Pollak MN; Basik M
Cancer; 2022 Apr; 128(7):1365-1372. PubMed ID: 34919263
[TBL] [Abstract][Full Text] [Related]
17. Risk and survival of chronic myeloid leukemia after breast cancer: A population-based study.
Al-Husseini MJ; Mohamed HH; Saad AM; Gad MM; Atia M; Qaddoora U; Abushouk AI; El-Shinawi M
Curr Probl Cancer; 2019 Jun; 43(3):213-221. PubMed ID: 30195804
[TBL] [Abstract][Full Text] [Related]
18. Minimal uterine serous carcinoma: current concepts in diagnosis and prognosis.
Rabban JT; Zaloudek CJ
Pathology; 2007 Feb; 39(1):125-33. PubMed ID: 17365828
[TBL] [Abstract][Full Text] [Related]
19. Papillary syncytial metaplasia associated with endometrial breakdown exhibits an immunophenotype that overlaps with uterine serous carcinoma.
McCluggage WG; McBride HA
Int J Gynecol Pathol; 2012 May; 31(3):206-10. PubMed ID: 22498936
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis, treatment and prognosis of uterine serous carcinoma].
Zhang F; Deng LS; Li B; Huang MN; Li XG; Zhang R; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2020 Dec; 55(12):848-856. PubMed ID: 33355760
[No Abstract] [Full Text] [Related]
[Next] [New Search]